首页> 外文OA文献 >Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

【2h】

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

机译：纯化靶向增强CD73 +固体肿瘤的免疫疗法，用储纸工程化的嵌合抗原受体天然杀伤细胞

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jiao Wang; Kyle B. Lupo; Andrea M. Chambers; Sandro Matosevic;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival [J] . Genssler Sabrina, Burger Michael C., Zhang Congcong, Oncoimmunology. . 2016,第4期

机译：嵌合抗原受体工程化的自然杀伤细胞对胶质母细胞瘤的双重靶向克服了靶抗原表达的异质性并增强了抗肿瘤活性和存活率
2. The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy [J] . Simon B., Wiesinger M., Maerz J., Experimental dermatology . 2019,第3期

机译：用肿瘤 - 抗原特异性嵌合抗原受体（CAR）对黑色素瘤免疫疗法的抗腐烂
3. Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy [J] . Zhang Jianguang, Zheng Huifang, Diao Yong Nature reviews neuroscience . 2019,第2期

机译：肿瘤免疫疗法中嵌合抗原受体改性NK-92细胞的自然杀伤细胞和目前应用
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
6. Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells [O] . Jiao Wang, Kyle B. Lupo, Andrea M. Chambers, 2018

机译：嘌呤能靶向增强通过piggyBac工程嵌合抗原受体天然杀伤细胞对CD73 +实体瘤的免疫治疗
7. Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy [O] . Jianguang Zhang, Huifang Zheng, Yong Diao 2019

机译：肿瘤免疫疗法中嵌合抗原受体改性NK-92细胞的自然杀伤细胞和目前应用

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

著录项

引文网络

相似文献

相关主题

期刊订阅